Total Payments
$20,220
2024 Payments
$3,128
Companies
78
Transactions
1,329
Medicare Patients
3,656
Medicare Billing
$654,871
Payment Breakdown by Category
Food & Beverage$19,740 (97.6%)
Education$288.15 (1.4%)
Other$191.87 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,740 | 1,311 | 97.6% |
| Education | $288.15 | 7 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191.87 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,740 | 180 | $0 (2024) |
| ABBVIE INC. | $1,086 | 80 | $0 (2024) |
| SK Life Science, Inc. | $996.11 | 62 | $0 (2024) |
| UCB, Inc. | $965.56 | 86 | $0 (2024) |
| Boston Scientific Corporation | $836.02 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $782.83 | 57 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $738.43 | 58 | $0 (2022) |
| Abbott Laboratories | $728.95 | 25 | $0 (2024) |
| Allergan, Inc. | $727.89 | 56 | $0 (2022) |
| PFIZER INC. | $717.47 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,128 | 176 | Boston Scientific Corporation ($297.46) |
| 2023 | $2,482 | 150 | ABBVIE INC. ($325.73) |
| 2022 | $2,490 | 139 | SK Life Science, Inc. ($334.25) |
| 2021 | $1,996 | 145 | AbbVie Inc. ($241.68) |
| 2020 | $2,025 | 140 | Teva Pharmaceuticals USA, Inc. ($262.82) |
| 2019 | $3,140 | 209 | Teva Pharmaceuticals USA, Inc. ($402.22) |
| 2018 | $2,701 | 209 | Teva Pharmaceuticals USA, Inc. ($553.97) |
| 2017 | $2,258 | 161 | UCB, Inc. ($231.91) |
All Payment Transactions
1,329 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 12/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $166.05 | General |
| Category: General - DBS_NMD | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $39.38 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $5.02 | General |
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $1.19 | General |
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $3.32 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $32.47 | General |
| 11/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Neurology | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 907 | 2,126 | $230,319 | $155,746 |
| 2022 | 10 | 858 | 2,094 | $225,785 | $157,535 |
| 2021 | 9 | 933 | 2,357 | $253,909 | $184,388 |
| 2020 | 11 | 958 | 2,080 | $230,397 | $157,203 |
Total Patients
3,656
Total Services
8,657
Medicare Billing
$654,871
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 416 | 837 | $114,156 | $75,441 | 66.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 164 | 164 | $38,312 | $25,529 | 66.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 133 | $25,137 | $17,727 | 70.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 75 | 145 | $15,660 | $11,359 | 72.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 34 | 35 | $14,295 | $10,648 | 74.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 54 | 54 | $10,854 | $7,647 | 70.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 14 | 14 | $4,480 | $3,233 | 72.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 24 | 56 | $3,818 | $2,545 | 66.7% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 12 | 12 | $1,860 | $1,080 | 58.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 676 | $1,747 | $536.40 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 381 | 818 | $111,433 | $75,341 | 67.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 153 | 153 | $36,112 | $25,456 | 70.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 113 | 155 | $29,342 | $21,646 | 73.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 42 | 42 | $17,105 | $13,265 | 77.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 59 | 110 | $12,628 | $8,776 | 69.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 34 | 36 | $7,364 | $5,375 | 73.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 13 | 13 | $4,160 | $3,142 | 75.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 25 | 58 | $3,886 | $2,768 | 71.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 13 | 13 | $2,015 | $1,155 | 57.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 25 | 696 | $1,740 | $611.08 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 399 | 905 | $122,611 | $86,492 | 70.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 164 | 164 | $38,292 | $27,247 | 71.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 109 | 156 | $29,389 | $21,501 | 73.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 46 | 48 | $19,440 | $15,265 | 78.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 77 | 167 | $18,160 | $14,178 | 78.1% |
About Dr. Sevak Ohanian, MD
Dr. Sevak Ohanian, MD is a Neurology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922180637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sevak Ohanian, MD has received a total of $20,220 in payments from pharmaceutical and medical device companies, with $3,128 received in 2024. These payments were reported across 1,329 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($19,740).
As a Medicare-enrolled provider, Ohanian has provided services to 3,656 Medicare beneficiaries, totaling 8,657 services with total Medicare billing of $654,871. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Katy, TX
- Active Since 10/20/2006
- Last Updated 02/10/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922180637
Products in Payments
- NURTEC ODT (Drug) $939.62
- APTIOM (Drug) $751.52
- RYTARY (Drug) $713.33
- BOTOX (Biological) $546.03
- Aimovig (Biological) $505.68
- AJOVY (Drug) $490.88
- INFINITY (Device) $489.71
- Xadago (Drug) $469.13
- QULIPTA (Drug) $431.52
- Vercise (Device) $408.03
- AJOVY (Biological) $404.66
- Neupro (Drug) $399.19
- UBRELVY (Drug) $399.14
- NUPLAZID (Drug) $397.68
- EMGALITY (Drug) $355.31
- AUBAGIO (Drug) $329.02
- NUEDEXTA (Drug) $325.06
- TECFIDERA (Drug) $324.35
- Briviact (Drug) $302.63
- AIMOVIG (Biological) $274.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Katy
Dr. Jose Diaz, M.d, M.D
Neurology — Payments: $105,577
Neurology $105,577
Dr. Ankit Patel, M.d, M.D
Neurology — Payments: $21,121
Neurology $21,121
Dr. Sadia Yasser, M.d, M.D
Neurology — Payments: $5,365
Neurology $5,365
Shima Bozorgui, Md, Mph, MD, MPH
Neurology — Payments: $155.34
Neurology $155.34
Ibrahim Noorbhai
Neurology — Payments: $40.16
Neurology $40.16
Hannah Sutherland, Pt, Dpt, PT, DPT
Neurology
Neurology